pcDNA3.1 E2F1 Flag(Δ193-359) (HindIII- BamHI- EcoRI)
(Plasmid
#70667)
-
PurposeHuman mutant of E2F1 lacking amino acids 193-359
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 70667 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA3.1
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameE2F1 lacking residues 193 to 359
-
Alt nameRBP3; E2F-1; RBAP1; RBBP3
-
SpeciesH. sapiens (human)
-
Insert Size (bp)993
-
Mutationlacks amino acids 193-359
-
GenBank IDNM_005225
-
Entrez GeneE2F1 (a.k.a. E2F-1, RBAP1, RBBP3, RBP3)
- Promoter cmv
-
Tag
/ Fusion Protein
- FLAG (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site HindIII BamHI (not destroyed)
- 3′ cloning site BamHI EcoRI (not destroyed)
- 5′ sequencing primer TAA TAC GAC TCA CTA TAG GG
- 3′ sequencing primer TAGAAGGCACAGTCGAGG (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byI did sub clone the E2F1 mutant from the E2F1 gene provided to me by Dr. Joseph R. Nevins
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pcDNA3.1 E2F1 Flag(Δ193-359) (HindIII- BamHI- EcoRI) was a gift from Maria Alvarado-Kristensson (Addgene plasmid # 70667 ; http://n2t.net/addgene:70667 ; RRID:Addgene_70667) -
For your References section:
Nuclear localization of gamma-tubulin affects E2F transcriptional activity and S-phase progression. Hoog G, Zarrizi R, von Stedingk K, Jonsson K, Alvarado-Kristensson M. FASEB J. 2011 Nov;25(11):3815-27. doi: 10.1096/fj.11-187484. Epub 2011 Jul 25. 10.1096/fj.11-187484 PubMed 21788450